Filtros : "Zeni, C. P." Limpar

Filtros



Refine with date range


  • Source: Genes, Brain and Behavior. Unidade: FM

    Subjects: FARMACOLOGIA (ESTUDO), FARMACOGENÉTICA, HIPERATIVIDADE

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BRUXEL, E. M. et al. LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study. Genes, Brain and Behavior, v. 14, n. 5, p. 419-427, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/gbb.12224/epdf. Acesso em: 10 maio 2024.
    • APA

      Bruxel, E. M., Salatino-Oliveira, A., Akutagava-Martins, G. C., Tovo-Rodrigues, L., Genro, J. P., Zeni, C. P., et al. (2015). LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study. Genes, Brain and Behavior, 14( 5), 419-427. doi:10.1111/gbb.12224
    • NLM

      Bruxel EM, Salatino-Oliveira A, Akutagava-Martins GC, Tovo-Rodrigues L, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Schmitz M, Arcos-Burgos M, Rohde LA, Hutz MH. LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study [Internet]. Genes, Brain and Behavior. 2015 ; 14( 5): 419-427.[citado 2024 maio 10 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/gbb.12224/epdf
    • Vancouver

      Bruxel EM, Salatino-Oliveira A, Akutagava-Martins GC, Tovo-Rodrigues L, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Schmitz M, Arcos-Burgos M, Rohde LA, Hutz MH. LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study [Internet]. Genes, Brain and Behavior. 2015 ; 14( 5): 419-427.[citado 2024 maio 10 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/gbb.12224/epdf
  • Source: The Pharmacogenomics Journal. Unidade: FM

    Subjects: POLIMORFISMO, CRIANÇAS, ADOLESCENTES, FARMACOGENÉTICA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BRUXEL, E. M. et al. Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate. The Pharmacogenomics Journal, v. 13, n. 5, p. 476-480, 2013Tradução . . Disponível em: https://doi.org/10.1038/tpj.2012.25. Acesso em: 10 maio 2024.
    • APA

      Bruxel, E. M., Salatino-Oliveira, A., Genro, J. P., Zeni, C. P., Polanczyk, G. V., Chazan, R., et al. (2013). Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate. The Pharmacogenomics Journal, 13( 5), 476-480. doi:10.1038/tpj.2012.25
    • NLM

      Bruxel EM, Salatino-Oliveira A, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Rohde LA, Hutz MH. Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate [Internet]. The Pharmacogenomics Journal. 2013 ; 13( 5): 476-480.[citado 2024 maio 10 ] Available from: https://doi.org/10.1038/tpj.2012.25
    • Vancouver

      Bruxel EM, Salatino-Oliveira A, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Rohde LA, Hutz MH. Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate [Internet]. The Pharmacogenomics Journal. 2013 ; 13( 5): 476-480.[citado 2024 maio 10 ] Available from: https://doi.org/10.1038/tpj.2012.25

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024